Family Site

The contents provided by this page are intended only for Australian healthcare professionals.
Please leave this site if you are not an Australian healthcare professional.

Indications Dosing Administration Device Safety Information

Device

No concerns anymore.
Remsima® SC is designed with patients in mind.

Device Info

Device perspective Product perspective
It’s
convenient
to use 1,2

2-step simple operation pen

Large inspection window / green plunger rod to show injection status

Extended finger flange / ergonomic plunger head for comfortable grip

Built-in needle guard / automatic needle cover to hide the needle safely

Long stability up to 28 days outside the fridge

It’s
safe from
allergy 1,3

Latex free to protect patients from latex allergy
- SC device containing latex can cause allergy

It
causes less pain

29-gauge/5-bevel needle for low injection pain. 3,4,5

Citrate free for low injection pain 1

    Characteristics

    2-STEP
    simple operation 1

    LATEX FREE
    for patients with allergies 1,3

    29-GAUGE/5-BEVEL
    needle with less pain 3,4,5

    CITRATE FREE
    for less pain 1

    UP TO 28 DAYS
    available outside the fridge 1

    Characteristics

    PASSIVE ACTIVATION
    for patients who prefer manual injection control 1

    29-GAUGE/5-BEVEL
    needle with less pain 3,4,5

    BUILT-IN NEEDLE GUARD
    to protect from needlestick after injection 1

    LATEX FREE
    for patients with allergies 1,3

    CITRATE FREE
    for less pain 1

    UP TO 28 DAYS
    available outside the fridge 1

References

1. Remsima® Summary of Product Characteristics. Available at: https://www.ema.europa.eu/en/documents/product-information/Remsima®-epar-product-information_en.pdf Accessed 4 Sep 2020.

2. Schwartzman, Sergio, and G James Morgan Jr. “Does route of administration affect the outcome of TNF antagonist therapy?.” Arthritis research & therapy vol. 6 Suppl 2,Suppl 2 (2004): S19-23. doi:10.1186/ar996

3. Celltrion Healthcare. Data on File. 2020

4. Glenski, Stephen, and Jill Conner. “29 gauge needles improve patient satisfaction over 27 gauge needles for daily glatiramer acetate injections.” Drug, healthcare and patient safety vol. 1 (2009): 81-6. doi:10.2147/dhps.s8495

5. Jaber, Amer et al. “A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis.” BMC neurology vol. 8 38. 10 Oct. 2008, doi:10.1186/1471-2377-8-38

Abbreviations

SC, subcutaneous